3-Month Discontinuation of Dual Antiplatelet Therapy after Ultimaster Sirolimus-Eluting Stent Implantation
Phase of Trial: Phase III
Latest Information Update: 14 Nov 2016
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms MODEL U-SES
- 14 Nov 2016 Last checked against ClinicalTrials.gov record.
- 07 Nov 2016 Status changed from not yet recruiting to recruiting.
- 21 Jul 2016 New trial record